Dr. Adam Luginbuhl

Dr. Luginbuhl is at the cutting edge of research bridging the gap of new immunotheraputic options, radioactive isotopes and surgery to offer a broad array of clinical trials and treatment options for head and neck cancer. His recent work with CDDO compounds in the laboratory have resulted in preventing some of the profound side effects experienced in radiation therapy.

Additionally he is deeply involved in Haitian mission work, taking 3-4 trips/year. He and his partners have performed the first free tissue transfer and continue to operate regularly in 2 different hospitals. He is leading a coalition to bring oncologic care to Haiti through radiation and chemotherapy.